BlackRock Discloses Passive Stake in ClearPoint Neuro
Ticker: CLPT · Form: SC 13G · Filed: Jan 29, 2024 · CIK: 1285550
| Field | Detail |
|---|---|
| Company | Clearpoint Neuro, Inc. (CLPT) |
| Form Type | SC 13G |
| Filed Date | Jan 29, 2024 |
| Risk Level | low |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, passive-investment, form-13g
TL;DR
**BlackRock just confirmed a big, passive stake in ClearPoint Neuro as of year-end 2023.**
AI Summary
BlackRock Inc., a major investment firm, reported on January 29, 2024, that as of December 31, 2023, it holds a significant stake in ClearPoint Neuro, Inc. This filing indicates BlackRock's passive ownership of ClearPoint Neuro's common stock, meaning they are not seeking to influence management. This matters to investors because large institutional holdings like BlackRock's can signal confidence in the company's long-term prospects and provide a degree of stability to the stock.
Why It Matters
This filing confirms a major institutional investor's position in ClearPoint Neuro, which can influence market perception and liquidity for the stock.
Risk Assessment
Risk Level: low — This is a routine disclosure of passive institutional ownership, which generally does not introduce new risks but rather confirms existing market positions.
Analyst Insight
An investor should note BlackRock's passive stake as a sign of institutional interest, but recognize this filing doesn't indicate any active management changes or new strategic moves by BlackRock.
Key Players & Entities
- BlackRock Inc. (company) — the investment firm filing the SC 13G
- ClearPoint Neuro, Inc. (company) — the subject company whose securities are being reported
- December 31, 2023 (date) — the date of the event requiring the filing
- January 29, 2024 (date) — the filing date of the SC 13G
FAQ
What type of filing is this document?
This document is an SC 13G filing, specifically under Rule 13d-1(b), which is used by passive institutional investors.
Which company is the subject of this filing?
The subject company of this filing is ClearPoint Neuro, Inc., with CIK 0001285550.
Who is the reporting person in this SC 13G filing?
The reporting person is BlackRock Inc., with CIK 0001364742.
What is the CUSIP number for the securities reported?
The CUSIP number for the Common Stock of ClearPoint Neuro, Inc. is 18507C103.
What was the 'Date of Event Which Requires Filing of this Statement'?
The 'Date of Event Which Requires Filing of this Statement' was December 31, 2023.
Filing Details
This Form SC 13G (Form SC 13G) was filed with the SEC on January 29, 2024 regarding ClearPoint Neuro, Inc. (CLPT).